Achieving Success in the Rare Disease Space

Lessons learned around commercializing new products in this niche sector

Andy Udell, North American president at Calliditas Therapeutics, a specialty pharma company, uncovers the complexities surrounding rare disease product commercialization, while also shedding light on outreach strategies that help spread awareness of new medications.

The latest episode of The Pharmaceutical Commerce Podcast is available directly on SoundCloud.

Related Content:

Editorial Podcasts
The Path Forward for Infused Biosimilars in the US
Nov. 27 is Here: What Does That Mean for DSCSA?
The Impact of RFID: Enhancing Medication Management